Concepedia

Manfred Plüer

MP

Statistics

Publications

1

Citations

28

H-Index

1

Active since

2022

Affiliations

Dynavax Technologies (United States)(Current)

Manfred Plüer is an author at Dynavax Technologies (United States).

Publications per year

2022–2022

1

Publications

1

Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study

Matthias Girndt, Manfred Plüer, Frank Dellanna et al. · Human Vaccines & Immunotherapeutics · 2022 · 28 citations · Full text

1–1 of 1